First successful pregnancy after addition of enoxaparin to sildenafil and etanercept immunotherapy in woman with fifteen failed IVF cycles - case report

Małgorzata Jerzak, Tomasz Niemiec, Anna Nowakowska, Monika Klochowicz, Andrzej Górski, Włodzimierz Baranowski
American journal of reproductive immunology (New York, N.Y. : 1989) · 2010 · doi:10.1111/j.1600-0897.2010.00826.x · PMID:20236261
case-report OA: closed public-domain-us
View on PubMed View at publisher

Abstract

PROBLEM: Does addition of enoxaparin to sildenafil and etanercept immunotherapy improve IVF outcome? METHODS: Report of a striking case with 15 IVF failures. RESULT: When enoxaparin was added, the 16th IVF cycle generated a healthy male baby. CONCLUSIONS: Combination therapy that includes a heparin may allow successful IVF outcome and this issue merits further study.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Anticoagulants Enoxaparin Fertilization in Vitro Immunoglobulin G Immunotherapy Piperazines Receptors, Tumor Necrosis Factor Sulfones Tumor Necrosis Factor-alpha Anticoagulants Cytotoxicity, Immunologic Cytotoxicity, Immunologic Drug Therapy, Combination Endometriosis Endometriosis Endometriosis Enoxaparin Etanercept Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
pubmed
last seen: 2026-05-13T22:17:18.915199+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine